Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.
UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.
In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone
The University of California San Diego has been ranked among the top 20 universities in the world, according to U.S. News and World Report’s 2022-2023 Best Global Universities.
UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
Building upon a long history, the UC San Diego has launched a new Human Milk Institute to accelerate research into the nature, biology and therapeutic potential of human milk to prevent or treat both infant and adult diseases. The new institute is believed to be the first of its kind in the United States.
Using a novel systems biology approach, scientists at UC San Diego School of Medicine have further parsed the cellular players and roles involved in rheumatoid arthritis, a complex disease that affects more than one million Americans in ways that have defied development of uniform treatments.
Experts at the San Diego Supercomputer Center at UC San Diego, San Diego State University and California State University, San Bernardino will apply NSF support to train and mentor a cohort of cyberinfrastructure professionals who will work closely with scientists to meet their computational needs.
Victor Nizet, MD, Distinguished Professor of Pediatrics at UC San Diego School of Medicine and Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, has been elected to the National Academy of Medicine.
UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.
From robots inspired by animals and even amoeba, to better algorithms for self-driving cars and robotic surgery, researchers at the University of California San Diego will be presenting a wide range of papers at IROS 2022, which returns in a hybrid format Oct. 23 to 27, 2022.
Facing extreme conditions such as starvation and stress, some bacterial cells enter a dormant state in which life processes stop. Biologists have discovered how they assess environmental conditions for a return to life, carrying implications for evaluating life on Earth as well as other planets.
UC San Diego researchers discover that quality and mix of protein in a type of pancreatic cancer is the determinant of whether the prognosis is poor or very poor.
A new system of algorithms developed by UC San Diego engineers enables four-legged robots to walk and run on challenging terrain while avoiding both static and moving obstacles. The work brings researchers a step closer to building robots that can perform search and rescue missions or collect information in places that are too dangerous or difficult for humans.
UC San Diego study finds enhanced PKCγ activity drives spinocerebellar ataxia type 14; suggests inhibiting the enzyme may have therapeutic potential
An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas — a survey of 35 types of cancer and their associated fungi
Through a highly competitive process, the Department of Energy (DOE) has announced $12.6 million in renewed funding for Quantum Materials for Energy Efficient Neuromorphic Computing (Q-MEEN-C) — led by the University of California San Diego.
In the first known study of its type, an international team of researchers evaluated whether high research and development costs explain high drug prices in the United States. They found no such association for 60 new drugs approved from 2009 to 2018.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
